AltrixBio Raises $5 Million Series A Financing and Appoints David Pass as CEO to Advance Lead...
/PRNewswire/ -- AltrixBio, a biopharmaceutical company pioneering treatments for cardiometabolic diseases, announced the closing of an initial $5 million...
prnewswire.com